Summary & Overview
HCPCS Level II P9025: Plasma, Cryoprecipitate-Reduced, Pathogen-Reduced, Each Unit
HCPCS Level II code P9025 denotes a single unit of plasma that has been cryoprecipitate-reduced and undergone pathogen-reduction processing. The code identifies a specialized blood product used in transfusion medicine to lower the risk of transfusion-related complications and minimize certain coagulation factor concentrations. Nationally, such processed plasma is relevant for hospitals, transfusion services, and outpatient infusion centers managing patients requiring plasma support while balancing safety and product availability.
Key payers discussed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of clinical context for use of pathogen-reduced, cryoprecipitate-reduced plasma, typical sites of service, and what to expect in billing and coding practice. The publication also summarizes benchmark considerations, common modifier usage (listed separately), and policy updates affecting coverage and reimbursement for specialized blood products. Clinical implications, billing line items, and payer coverage patterns are presented to inform administrative, revenue cycle, and clinical teams.
Billing Code Overview
HCPCS Level II code P9025 describes plasma, cryoprecipitate reduced, pathogen reduced, each unit. This item represents a processed blood product in which cryoprecipitate has been removed and additional pathogen-reduction steps have been applied to reduce transfusion-transmitted infection risk.
-
Service type: Blood product transfusion supply
-
Typical site of service: Hospital inpatient, hospital outpatient, transfusion center, or other infusion/clinical settings where blood products are administered
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult hospitalized for active bleeding or with high bleeding risk who requires transfusion support with specialized plasma product. The transfusion service receives an order for P9025 (plasma, cryoprecipitate reduced, pathogen reduced, each unit`) for a patient with coagulopathy due to liver disease, massive transfusion protocol, or perioperative bleeding. The clinical workflow: the ordering clinician documents indication and consent in the medical record; the transfusion medicine or blood bank staff verify patient identifiers and antibody screen; they locate and prepare a pathogen-reduced, cryoprecipitate-reduced plasma unit; pretransfusion vitals and compatibility checks are performed at the bedside; the unit is administered per institutional transfusion protocol with monitoring for transfusion reactions; documentation of unit number, start/stop times, volume, and any reactions is recorded in the chart; post-transfusion labs (e.g., INR, fibrinogen) are obtained as indicated to assess hemostatic response.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 | No modifier / Not applicable | Rarely appended; typically not used for HCPCS Level II when a specific modifier is required. |